In silico screening of Moringa oleifera derived bioactive compounds targeting FOXO1 and PTEN in oral cancer

Oral cancer (OC) remains a significant global health burden due to the high recurrence rates after conventional treatment. Medicinal plants have provided therapeutic leads for cancer for centuries and Moringa oleifera (MO) is rich in potentially anticancer phytochemicals. This in-silico study evaluated twenty MO-derived bioactive compounds against OC proliferation by targeting FOXO1 and PTEN, two key tumor suppressors regulating apoptosis, cell cycle, and PI3K/AKT signaling. Loss of FOXO1 and inactivation of PTEN contribute to oral carcinogenesis, therapeutic resistance, and poor prognosis, making them rational therapeutic targets. The ADMET properties were predicted with SwissADME and ProTox-III and the binding affinities of the MO compounds to FOXO1 and PTEN were evaluated with molecular docking in comparison with 5’-Fluorouracil (5’-FU) as reference. FOXO1 showed the best affinity for Pterygospermin (-8.6 kcal/mol) followed by Isorhamnetin (-8.3), Quercetin (-8.1), Kaempferol (-8.1), Myricetin (-8.1) and Apigenin (-8.0), all significantly better than 5’-FU (-5.0). For PTEN, the highest score was for Apigenin (-7.9), followed by Myricetin (-7.7), Kaempferol (-7.6), Quercetin (-7.4) and Isorhamnetin (-7.4), compared to 5-FU (-4.9). Toxicity predictions indicated that some compounds may have the risks of being carcinogenic, mutagenic or immunotoxic. However, Pterygospermin, Apigenin and several others showed no predicted toxicity with favorable drug-likeness, pharmacokinetics and adequate predicted oral bioavailability. These results indicate that MO-derived compounds are promising candidates for individualized therapy of OC. But the results are of predicted binding, not verified activation. Molecular dynamics, in-vitro, in-vivo and pre-clinical validation are required to confirm efficacy, safety and mechanism.

Authors

Institutions

Publication Details

Journal
Discover Chemistry.
Published
2026-11-12
DOI
https://doi.org/10.1007/s44371-026-01076-8
Primary Topic
Moringa oleifera research and applications
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

In silico screening of Moringa oleifera derived bioactive compounds targeting FOXO1 and PTEN in oral cancer

Prateek Kumar, Mausumi Bharadwaj, Chandrabhan Seniya, Varun Rawat et al.
Discover Chemistry.
Moringa oleifera research and applications
article

In silico screening of Moringa oleifera derived bioactive compounds targeting FOXO1 and PTEN in oral cancer

Prateek Kumar, Mausumi Bharadwaj, Chandrabhan Seniya, Varun Rawat, Mohammad Sajid, Pragya Sharma, Madhu Rani, Pramod Kumar, Sunidhi Sharma, Jiya Khasdev
article en

Abstract

Oral cancer (OC) remains a significant global health burden due to the high recurrence rates after conventional treatment. Medicinal plants have provided therapeutic leads for cancer for centuries and Moringa oleifera (MO) is rich in potentially anticancer phytochemicals. This in-silico study evaluated twenty MO-derived bioactive compounds against OC proliferation by targeting FOXO1 and PTEN, two key tumor suppressors regulating apoptosis, cell cycle, and PI3K/AKT signaling. Loss of FOXO1 and inactivation of PTEN contribute to oral carcinogenesis, therapeutic resistance, and poor prognosis, making them rational therapeutic targets. The ADMET properties were predicted with SwissADME and ProTox-III and the binding affinities of the MO compounds to FOXO1 and PTEN were evaluated with molecular docking in comparison with 5’-Fluorouracil (5’-FU) as reference. FOXO1 showed the best affinity for Pterygospermin (-8.6 kcal/mol) followed by Isorhamnetin (-8.3), Quercetin (-8.1), Kaempferol (-8.1), Myricetin (-8.1) and Apigenin (-8.0), all significantly better than 5’-FU (-5.0). For PTEN, the highest score was for Apigenin (-7.9), followed by Myricetin (-7.7), Kaempferol (-7.6), Quercetin (-7.4) and Isorhamnetin (-7.4), compared to 5-FU (-4.9). Toxicity predictions indicated that some compounds may have the risks of being carcinogenic, mutagenic or immunotoxic. However, Pterygospermin, Apigenin and several others showed no predicted toxicity with favorable drug-likeness, pharmacokinetics and adequate predicted oral bioavailability. These results indicate that MO-derived compounds are promising candidates for individualized therapy of OC. But the results are of predicted binding, not verified activation. Molecular dynamics, in-vitro, in-vivo and pre-clinical validation are required to confirm efficacy, safety and mechanism.

Discover Chemistry.Vol. 3(1)
Indian Council of Medical Research (IN), National Institute of Cancer Prevention and Research (IN), Manipal University Jaipur (IN), Academy of Scientific and Innovative Research (IN)
Indian Council of Medical Research, University of Delhi, Ministry of Health and Family Welfare, Department of Health Research, India
Good health and well-being
Moringa oleifera research and applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon